294 related articles for article (PubMed ID: 25076245)
1. Expression of CD44v3, erythropoietin and VEGF-C in gastric adenocarcinomas: correlations with clinicopathological features.
Wang L; Li HG; Wen JM; Peng TS; Zeng H; Wang LY
Tumori; 2014; 100(3):321-7. PubMed ID: 25076245
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of erythropoietin and erythropoietin receptor in gastric adenocarcinoma.
Wang L; Li HG; Xia ZS; Wen JM; Lv J
World J Gastroenterol; 2011 Sep; 17(34):3933-40. PubMed ID: 22025882
[TBL] [Abstract][Full Text] [Related]
3. CD44v3 and VEGF-C expression and its relationship with lymph node metastasis in squamous cell carcinomas of the uterine cervix.
Liu YQ; Li HF; Han JJ; Tang QL; Sun Q; Huang ZQ; Li HG
Asian Pac J Cancer Prev; 2014; 15(12):5049-53. PubMed ID: 24998585
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor-D and its receptor VEGFR-3: two novel independent prognostic markers in gastric adenocarcinoma.
Jüttner S; Wissmann C; Jöns T; Vieth M; Hertel J; Gretschel S; Schlag PM; Kemmner W; Höcker M
J Clin Oncol; 2006 Jan; 24(2):228-40. PubMed ID: 16344322
[TBL] [Abstract][Full Text] [Related]
5. Lymphangiogenesis and prognostic significance of vascular endothelial growth factor C in gastro-oesophageal junction adenocarcinoma.
Xie LX; Zhai TT; Yang LP; Yang E; Zhang XH; Chen JY; Zhang H
Int J Exp Pathol; 2013 Feb; 94(1):39-46. PubMed ID: 23317352
[TBL] [Abstract][Full Text] [Related]
6. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
[TBL] [Abstract][Full Text] [Related]
7. Expression of carbonic anhydrase IX (CA IX), a hypoxia-related protein, rather than vascular-endothelial growth factor (VEGF), a pro-angiogenic factor, correlates with an extremely poor prognosis in esophageal and gastric adenocarcinomas.
Driessen A; Landuyt W; Pastorekova S; Moons J; Goethals L; Haustermans K; Nafteux P; Penninckx F; Geboes K; Lerut T; Ectors N
Ann Surg; 2006 Mar; 243(3):334-40. PubMed ID: 16495697
[TBL] [Abstract][Full Text] [Related]
8. [Expression of vascular endothelial growth factors (VEGF)-A, -C and -D and their prognostic significance and relationship with angio- and lymphangiogenesis in gastric cancer].
Wang XL; Ai ZS; Fang JP; Tang RY; Chen XM
Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):837-43. PubMed ID: 19173829
[TBL] [Abstract][Full Text] [Related]
9. VEGF-C expression in squamous cell carcinoma and adenocarcinoma of the esophagus.
Möbius C; Freire J; Becker I; Feith M; Brücher BLDM; Hennig M; Siewert JR; Stein HJ
World J Surg; 2007 Sep; 31(9):1768-1772. PubMed ID: 17354029
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor C and microvessel density in gastric carcinoma: correlation with clinicopathological factors. Our experience and review of the literature.
Aurello P; Rossi Del Monte S; D'Angelo F; Cicchini C; Ciardi A; Bellagamba R; Ravaioli M; Ramacciato G
Oncol Res; 2009; 17(9):405-11. PubMed ID: 19718947
[TBL] [Abstract][Full Text] [Related]
11. Protein expression of HER2, 3, 4 in gastric cancer: correlation with clinical features and survival.
He XX; Ding L; Lin Y; Shu M; Wen JM; Xue L
J Clin Pathol; 2015 May; 68(5):374-80. PubMed ID: 25731189
[TBL] [Abstract][Full Text] [Related]
12. Expression of CD44 and its variant isoform v3 has no prognostic value in gastric cancer.
Setälä L; Lipponen P; Tammi R; Tammi M; Eskelinen M; Alhava E; Kosma VM
Histopathology; 2001 Jan; 38(1):13-20. PubMed ID: 11135041
[TBL] [Abstract][Full Text] [Related]
13. Correlation of decreased expression of PHLDA1 protein with malignant phenotype of gastric adenocarcinoma.
Zhao P; Lu Y; Liu L
Int J Clin Exp Pathol; 2015; 8(5):5230-5. PubMed ID: 26191222
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.
Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ
World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949
[TBL] [Abstract][Full Text] [Related]
15. Expression of vascular endothelial growth factors C and D correlates with lymphangiogenesis and lymph node metastasis in lung adenocarcinoma.
Bo C; Xiaopeng D; Chuanliang P; Xiaogang Z
Thorac Cardiovasc Surg; 2009 Aug; 57(5):291-4. PubMed ID: 19629892
[TBL] [Abstract][Full Text] [Related]
16. IMP3 is a novel biomarker to predict metastasis and prognosis of gastric adenocarcinoma: a retrospective study.
Wang L; Li HG; Xia ZS; Lü J; Peng TS
Chin Med J (Engl); 2010 Dec; 123(24):3554-8. PubMed ID: 22166630
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor and survivin immunostaining in gastric adenocarcinoma.
Bury J; Szumiło J; Dąbrowski A; Ciechański A; Śliwińska J; Wallner G
Pol Przegl Chir; 2012 Jul; 84(7):341-7. PubMed ID: 22935455
[TBL] [Abstract][Full Text] [Related]
18. Expression of cyclooxygenase 2 and vascular endothelial growth factor in gastric carcinoma: Relationship with clinicopathological parameters.
Hafez NH; Tahoun NS
J Egypt Natl Canc Inst; 2016 Sep; 28(3):149-56. PubMed ID: 27342370
[TBL] [Abstract][Full Text] [Related]
19. The association of VEGF-C expression with tumor lymphatic vessel density and lymph node metastasis in patients with gastric cancer and gastrointestinal stromal tumor.
Kigure W; Fujii T; Sutoh T; Morita H; Katoh T; Yajima RN; Yamaguchi S; Tsutsumi S; Asao T; Kuwano H
Hepatogastroenterology; 2013; 60(122):277-80. PubMed ID: 23574654
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor C (VEGF-C) expression in pT2 gastric cancer.
Tsutsumi S; Kuwano H; Shimura T; Morinaga N; Mochiki E; Asao T
Hepatogastroenterology; 2005; 52(62):629-32. PubMed ID: 15816493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]